Preimplantation testing refers to the chromosomal or specific gene testing of embryos before implantation. This is done to select embryos that do not carry genetic defects for implantation into the uterus. This allows couples facing high genetic risks during pregnancy to avoid natural miscarriages, prenatal termination, or birth defects caused by genetic diseases. The ultimate goal is to achieve healthy offspring.
The Principle of Preimplantation Testing
By using high-throughput sequencing technology (Next Generation Sequencing, NGS), single-cell whole-genome amplification products are sequenced to obtain thousands of reads (base sequences). These are then compared to reference sequences of the human genome to map the reads onto the genome.
By selecting windows of a certain length, the number of reads within these windows can be counted, thereby serving as the signal value (digital signal) for that window. This signal tends to stabilize as the sequencing depth and window size increase. These windows with stable signal values are the basis for determining chromosomal abnormalities. For a diploid region (or an entire chromosome), if the signal value is 1.5 times the normal value, it can be determined as a duplication (or triploid). If it is 0.5 times the normal value, it can be determined as a deletion (or haploid).
Benefits of Preimplantation Testing
Increased Clinical Pregnancy and Live Birth Rates
Preimplantation testing screens embryos for genetic abnormalities before implantation, thereby excluding embryos carrying genetic diseases or chromosomal anomalies. This helps in selecting healthy embryos for transfer, increasing the chances of successful pregnancy.
Reduced Risk of Early Miscarriage
Preimplantation testing can effectively identify embryos with chromosomal abnormalities, such as numerical or structural anomalies. By excluding these embryos, the risk of transferring unhealthy embryos into the uterus is avoided, significantly reducing the risk of early miscarriage.
Reduction in the Birth of Children with Genetic Defects
Preimplantation testing helps in screening embryos that carry genetic defects or high-risk genes, preventing the implantation of embryos with hereditary diseases such as Thalassemia, Cystic Fibrosis, or Down Syndrome.
Increased Success Rate of Single Embryo Pregnancies
Gene screening before embryo implantation can also effectively increase the success rate of single embryo pregnancies. By selecting the healthiest embryo among multiple embryos, complications associated with multiple pregnancies, such as premature birth, low birth weight, and pregnancy-induced hypertension, can be avoided.
Why Choose Microarrays over Other Technologies?November 10, 2023Microarrays are becoming an increasingly popular choice for biologists and researchers worldwide. With the help of advanced technology, these arrays provide a cost-effective and efficient way to analy...view
Prostate Cancer (PCA) Is A Difficult Disease To UnderstandJune 28, 2022Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. On the other hand, non-genetic intra-t...view
Applications of Microarray Platforms in Modern Biological ResearchApril 2, 2026Microarray platforms are essential tools in genomics and molecular biology, providing an efficient and high-throughput method for simultaneously measuring the expression of thousands of genes or detec...view
Development of Transcriptome Sequencing TechnologyApril 4, 2023Transcriptome refers to the total sum of all expressed genes in a specific cell under specific functional conditions, which includes all transcript information of a cell. Typically, transcriptome anal...view
What Are the Main Processes of DNA Microarray Technology?March 8, 2023The principle of DNA microarray technology is to integrate gene probes with known sequences onto a solid surface. A large number of labeled nucleic acid sequences from the tested biological cells or t...view